Navigation Links
Benefits and Risks of Asthma Treatment Questioned

Government guidelines on the treatment of asthma have long recommended inhaled corticosteroid (ICS) therapy as the best treatment for people with persistent forms of the condition.But reports about side effects //of these drugs have led many people -- including parents of asthmatic children -- to question their use. Specifically, ICS has been linked to growth retardation in children, weak bones in children and adults, skin thinning, and eye problems.

Now leading scientists hope to put those fears to rest. Three medical groups -- the American College of Chest Physicians, the American Academy of Allergy, Asthma, and Immunology, and the American College of Allergy, Asthma, and Immunology -- have teamed up to publish a systematic review of the medical evidence on ICS therapy and related side effects. Their conclusion is that the therapy is safe and effective and should remain the gold standard of treatment.

According to the report, published :
?h ICS therapy is not associated with bone thinning in children. ?h ICS therapy is linked to skin thinning and bruising in both adults and children, but the effects are mostly related to dose, length of use, and the gender of the patient. ?h ICS therapy is associated with a decrease in childhood growth rates, but the effect is small and studies suggest it may not persist with long-term therapy. Adult height of asthmatic children treated with ICS therapy is not substantially different from adult height attained by nonasthmatic children.

Conclusions could not be drawn on the effect of ICS therapy on bone thinning in adults or eye problems such as cataracts and glaucoma due to a lack of sufficient medical evidence.

Researchers from Thomas Jefferson University in Philadelphia, say, ?§After a systematic and accurate review of the proven risks, we can say with confidence that the majority of evidence supports the conclusion that the clinical effectiveness of ICS therapy decidedly outweighs t he proven risks.?¨


'"/>




Related medicine news :

1. Benefits in fertility procedures
2. Benefits of Vitamin Supplements Unclear
3. Benefits of Eating Whole Grains, Fruits and Vegetables
4. Benefits of Nitric Oxide in the Treatment of Premature Infants
5. Benefits Of The Worlds Most Widely Used Beverage
6. Drug In Asthma inhaler Found To Counteract Benefits
7. The Benefits Of Keyhole Surgery
8. The Benefits Of A Stretch
9. A Reduction In Calories Found To Yield More Benefits
10. The Benefits Of Soy
11. Benefits Of Fruits and Veggies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... 19, 2017 , ... Curl Keeper® is excited to announce that the H2O ... 2017 Award for the second year in a row. The H2O Bottle, a refillable ... voted Best Moisturizer for Type 2 Wavies and Best Refresher for Type 2 Wavies ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... has joined its Orlando location as an interventional pain management physician. He brings ... on the treatment of migraine headaches, and significant experience in spinal cord stimulation ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / jteixeira@thenc.org , ... from their Fathers , Contrary to a father’s perception, ...
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... asset protection assistance to communities in North-Central West Virginia, is embarking on a ... at-risk boys in the area. , The Chestnut Mountain Ranch (CMR) is a ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... third quarter of 2017. ... on or about October 27, 2017 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:8/7/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... 30, 2017.  All comparisons, unless otherwise noted, are to the ... Second Quarter 2017 Highlights include: ... increase of 3.5% Total prescriptions dispensed of ... 7.5% versus 7.6% Gross profit per ...
Breaking Medicine Technology: